Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 15-16, 2010, Pages 1085-1092

  van den Broek, Irene ^a   Sparidans, Rolf W ^a   Schellens, Jan H M ^a,b   Beijnen, Jos H ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Human neutrophil peptides; LC MS MS; Quantification

Indexed keywords

ANTIMICROBIAL PEPTIDE; AVERAGE CONCENTRATION; CHARGED IONS; CHROMATOGRAPHIC SEPARATIONS; DEFENSINS; ENDOGENOUS CONCENTRATION; FRAGMENTATION EFFICIENCY; HUMAN NEUTROPHIL; HUMAN NEUTROPHIL PEPTIDES; HUMAN PLASMAS; INTENSIVE-CARE PATIENTS; INTER-ASSAY PRECISION; INTERNAL STANDARDS; LC-MS/MS; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY COUPLED TO TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LOWER LIMIT OF QUANTIFICATIONS; MULTIPLE REACTION MONITORING; QUANTITATIVE ASSAY; SERUM SAMPLES; SIMULTANEOUS MEASUREMENT; TANDEM MASS SPECTROMETRIC DETECTION; TRIPLE-QUADRUPOLE MASS SPECTROMETER; WATER-METHANOL;

BODY FLUIDS; CONCENTRATION (PROCESS); ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; METHANOL; ORGANIC ACIDS; PLASMA (HUMAN); PLASMAS; PRECIPITATION (CHEMICAL);

PEPTIDES;

C REACTIVE PROTEIN; DEFENSIN 1; DEFENSIN 2; DEFENSIN 3; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; INTENSIVE CARE; LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

ALPHA-DEFENSINS; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HUMANS; INTENSIVE CARE UNITS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 77951094005     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.03.014     Document Type: Article

References (29)

1. Szyk A., Wu Z., Tucker K., Yang D., Lu W., and Lubkowski J. Protein Sci. 15 (2006) 2749
2. Ganz T., and Lehrer R.I. Curr. Opin. Immunol. 6 (1994) 584
3. Ihi T., Nakazato M., Mukae H., and Matsukura S. Clin. Infect. Dis. 25 (1997) 1134
4. Lehrer R.I., Ganz T., and Selsted M.E. Cell 64 (1991) 229
5. Wu Z., Ericksen B., Tucker K., Lubkowski J., and Lu W. J. Pept. Res. 64 (2004) 118
6. Shiomi K., Nakazato M., Ihi T., Kangawa K., Matsuo H., and Matsukura S. Biochem. Biophys. Res. Commun. 195 (1993) 1336
7. Panyutich A.V., Panyutich E.A., Krapivin V.A., Baturevich E.A., and Ganz T. J. Lab. Clin. Med. 122 (1993) 202
8. Mukae H., Iiboshi H., Nakazato M., Hiratsuka T., Tokojima M., Abe K., Ashitani J., Kadota J., Matsukura S., and Kohno S. Thorax 57 (2002) 623
9. Mukae H., Ishimoto H., Yanagi S., Ishii H., Nakayama S., Ashitani J., Nakazato M., and Kohno S. Respir. Med. 101 (2007) 715
10. Ashitani J., Mukae H., Hiratsuka T., Nakazato M., Kumamoto K., and Matsukura S. Chest 121 (2002) 519
11. Ashitani J., Mukae H., Arimura Y., Sano A., Tokojima M., and Nakazato M. Life Sci. 75 (2004) 1123
12. Ashitani J., Mukae H., Nakazato M., Ihi T., Mashimoto H., Kadota J., Kohno S., and Matsukura S. Eur. Respir. J. 11 (1998) 104
13. Albrethsen J., Bogebo R., Gammeltoft S., Olsen J., Winther B., and Raskov H. BMC Cancer 5 (2005) 8
14. Albrethsen J., Moller C.H., Olsen J., Raskov H., and Gammeltoft S. Eur. J. Cancer 42 (2006) 3057
15. Kanmura S., Uto H., Numata M., Hashimoto S., Moriuchi A., Fujita H., Oketani M., Ido A., Kodama M., Ohi H., and Tsubouchi H. Inflamm. Bowel Dis. (2008)
16. Melle C., Ernst G., Schimmel B., Bleul A., Thieme H., Kaufmann R., Mothes H., Settmacher U., Claussen U., Halbhuber K.J., and Von Eggeling F. Gastroenterology 129 (2005) 66
17. Mohri Y., Mohri T., Wei W., Qi Y.J., Martin A., Miki C., Kusunoki M., Ward D.G., and Johnson P.J. Br. J. Cancer 101 (2009) 295
18. Mothes H., Melle C., Ernst G., Kaufmann R., von Eggeling F., and Settmacher U. Dis. Markers 25 (2008) 123
19. Yamaguchi N., Isomoto H., Mukae H., Ishimoto H., Ohnita K., Shikuwa S., Mizuta Y., Nakazato M., and Kohno S. Inflamm. Res. 58 (2009) 192
20. Muller C.A., Markovic-Lipkovski J., Klatt T., Gamper J., Schwarz G., Beck H., Deeg M., Kalbacher H., Widmann S., Wessels J.T., Becker V., Muller G.A., and Flad T. Am. J. Pathol. 160 (2002) 1311
21. Vlahou A., Schellhammer P.F., Mendrinos S., Patel K., Kondylis F.I., Gong L., Nasim S., and Wright Jr. G.L. Am. J. Pathol. 158 (2001) 1491
22. Mizukawa N., Sugiyama K., Fukunaga J., Ueno T., Mishima K., Takagi S., and Sugahara T. Anticancer Res. 18 (1998) 4645
23. Mizukawa N., Sugiyama K., Ueno T., Mishima K., Takagi S., and Sugahara T. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 87 (1999) 539
24. Mizukawa N., Sugiyama K., Ueno T., Mishima K., Takagi S., and Sugahara T. Oral Dis. 5 (1999) 139
25. Goebel C., Mackay L.G., Vickers E.R., and Mather L.E. Peptides 21 (2000) 757
26. Guidance for industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CEDR), Center for Veterinary Medicine (CVM), BP, May 2001. http://www.fda.gov/cder/guidance/4252fnl.htm.
27. van den Broek I., Sparidans R.W., Schellens J.H., and Beijnen J.H. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 872 (2008) 1
28. van den Broek I., Sparidans R.W., Schellens J.H., and Beijnen J.H. Rapid Commun. Mass Spectrom. 22 (2008) 2915
29. Villanueva J., Shaffer D.R., Philip J., Chaparro C.A., Erdjument-Bromage H., Olshen A.B., Fleisher M., Lilja H., Brogi E., Boyd J., Sanchez-Carbayo M., Holland E.C., Cordon-Cardo C., Scher H.I., and Tempst P. J. Clin. Invest. 116 (2006) 271